Figures & data
Figure 2 Median fold–change differences in alteration of miRNA expression between patient and control (normal). microRNAmiRNA expression analyzed using 2−ΔΔCt.
![Figure 2 Median fold–change differences in alteration of miRNA expression between patient and control (normal). microRNAmiRNA expression analyzed using 2−ΔΔCt.](/cms/asset/e8a803c3-5e56-4805-9c46-d8cad6fdb325/djbm_a_230842_f0002_b.jpg)
Figure 3 Deregulation of miR25-3p (A) and miR19a-3p (B) in CLL samples. Relative expression of miR-miR25-3p and miR-miR19a-3p in CLL samples compared to control. Expression normalized to 5s rRNA (endogenous control). Significant differences miR-miR25-3p between control and patients (****P=0.0001) and miR-miR19a-3p (***P=0.001). Results presented as mean ± SD of three independent experiments, each performed in triplicate.
![Figure 3 Deregulation of miR25-3p (A) and miR19a-3p (B) in CLL samples. Relative expression of miR-miR25-3p and miR-miR19a-3p in CLL samples compared to control. Expression normalized to 5s rRNA (endogenous control). Significant differences miR-miR25-3p between control and patients (****P=0.0001) and miR-miR19a-3p (***P=0.001). Results presented as mean ± SD of three independent experiments, each performed in triplicate.](/cms/asset/f4c13b0c-73b3-4634-b82d-8a70e41d5f05/djbm_a_230842_f0003_c.jpg)
Table 1 Intracellular Targets and Functions of miRNAs